Insider Trading November 16, 2026 07:35 AM

Hinge Health Co-Founder Mecklenburg Offloads $24.48M in Shares Near 52-Week High

Executive chairman sells 200,000 Class A shares under pre-arranged plan, converts equivalent Class B stock, and retains indirect holdings through trusts.

By Jordan Park
Share
Twitter Reddit Facebook LinkedIn
HNGE

Gabriel M.I. Mecklenburg, Executive Chairman and Co-Founder of Hinge Health, sold 200,000 Class A shares for $24,482,096 on November 11, 2026, at weighted average prices between $121.7581 and $125.5041, close to the stock's 52-week high of $126.40. The sale was conducted under a Rule 10b5-1 trading plan adopted on June 12, 2026. On the same day, Mecklenburg converted 200,000 Class B shares into Class A shares at no cost. Following these transactions, he directly holds no Class A Common Stock but retains 1,444,004 Class B shares directly, plus 383,592 Class B shares indirectly through a Family Trust and 692,710 Class B shares through a Grantor Retained Annuity Trust (GRAT). The company recently reported third-quarter revenue of $235 million, a 52% year-over-year increase, surpassing both Canaccord's $224 million estimate and the company's guidance of $223 million to $225 million. Non-GAAP operating income was $77.2 million with a 33% margin, exceeding Canaccord's $62.7 million estimate and 28% margin expectation. Stifel, Canaccord, Needham, and Wells Fargo all raised their price targets for Hinge Health, reflecting confidence in the company's performance. Stifel increased its target to $135, Canaccord set theirs at $134, Needham raised its target to $135 citing strong client growth, and Wells Fargo adjusted its price target to $132, noting yield strength and exceeding consensus estimates in revenue and adjusted EBIT.

Hinge Health Co-Founder Mecklenburg Offloads $24.48M in Shares Near 52-Week High
HNGE
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Executive Chairman and Co-Founder Gabriel M.I. Mecklenburg sold 200,000 Class A shares for $24.48 million at weighted average prices between $121.7581 and $125.5041, near the 52-week high of $126.40, under a Rule 10b5-1 plan adopted on June 12, 2026.
  • Mecklenburg converted 200,000 Class B shares to Class A at no cost and now directly holds no Class A shares, while retaining 1,444,004 Class B shares directly and additional Class B shares indirectly through a Family Trust and a GRAT.
  • Hinge Health's third-quarter revenue of $235 million (up 52% year-over-year) and non-GAAP operating income of $77.2 million (33% margin) exceeded analyst expectations, prompting Stifel, Canaccord, Needham, and Wells Fargo to raise their price targets.

Gabriel M.I. Mecklenburg, Executive Chairman and Co-Founder of Hinge Health, Inc. (NASDAQ:HNGE), sold 200,000 shares of the company's Class A Common Stock for a total of $24,482,096 on November 11, 2026, according to a regulatory filing. The shares were sold at weighted average prices ranging from $121.7581 to $125.5041 per share, a range that sits close to the stock's 52-week high of $126.40. The company has delivered a 182% return over the past year, though an analysis provided by InvestingPro suggests the stock is currently overvalued relative to its Fair Value.

The sales were executed pursuant to a Rule 10b5-1 trading plan, which Mecklenburg adopted on June 12, 2026. Such plans allow company insiders to set up predetermined schedules for buying or selling shares, providing a defense against allegations of trading on material nonpublic information.

On the same day, Mecklenburg also converted 200,000 shares of Class B Common Stock into Class A Common Stock at no cost. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election or automatically upon certain transfers or events.

Following these transactions, Mecklenburg directly holds no Class A Common Stock. He continues to hold 1,444,004 shares of Class B Common Stock directly. In addition, he indirectly holds 383,592 shares of Class B Common Stock through a Family Trust and 692,710 shares of Class B Common Stock through a Grantor Retained Annuity Trust (GRAT).

In other recent news, Hinge Health reported strong financial performance in the third quarter, with revenue reaching $235 million, marking a 52% increase year-over-year. This figure surpassed both Canaccord's estimate of $224 million and the company's guidance of $223 million to $225 million. The company's non-GAAP operating income was $77.2 million, with a margin of 33%, exceeding Canaccord's expectations of $62.7 million and a 28% margin.

Stifel, Canaccord, Needham, and Wells Fargo all raised their price targets for Hinge Health, reflecting confidence in the company's performance. Stifel increased its target to $135, while Canaccord set theirs at $134. Needham also raised its target to $135, citing strong client growth as a significant factor. Wells Fargo adjusted its price target to $132, noting the company's yield strength and exceeding consensus estimates in revenue and adjusted EBIT. These developments highlight the positive sentiment among analysts regarding Hinge Health's recent achievements.

Risks

  • The sale occurred near the stock's 52-week high, and an analysis provided by InvestingPro suggests the stock may be overvalued relative to its Fair Value, which could indicate limited upside or potential for a price correction.
  • The conversion of Class B to Class A shares and subsequent sale reduces Mecklenburg's direct Class A holdings to zero, which may raise questions about insider confidence, although the transaction was executed under a pre-arranged 10b5-1 plan.
  • Analyst price target increases reflect recent strong performance, but future results may not sustain the same growth trajectory, and the stock's high valuation could make it vulnerable to shifts in sentiment.

More from Insider Trading

CorMedix CEO Joseph Todisco Purchases $391,200 in Company Shares Nov 16, 2026 IBEX People Chief Offloads $100K in Stock as Shares Climb to Near 52-Week High Nov 15, 2026 Marqeta CAO Sumner Crystal Offloads 1,250 Shares in $20,487 Open-Market Sale Nov 15, 2026 Wayfair Director Conine Offloads $7.13 Million in Stock Under Pre-Arranged Plan Nov 15, 2026 IBEX Legal Chief Offloads $395,727 in Shares as Stock Soars to Near 52-Week High Nov 15, 2026